Related references
Note: Only part of the references are listed.Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation
Kirstin Andersen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake
Shuyun Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
Berthold Hocher et al.
NATURE REVIEWS NEPHROLOGY (2017)
Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound
Jorge E. Toblli et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Glucagon-like peptide-1 and vitamin D: anti-inflammatory response in diabetic kidney disease in db/db mice and in cultured endothelial cells
Yael Einbinder et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice
Qing-hua Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
Satoru Takashima et al.
KIDNEY INTERNATIONAL (2016)
Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy
Jingping Liu et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress
S. Xu et al.
CELL DEATH & DISEASE (2015)
Mitochondrial alteration in type 2 diabetes and obesity An epigenetic link
Zhiyong Cheng et al.
CELL CYCLE (2014)
SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis
Fen Xu et al.
DIABETES (2014)
Novel insights of dietary polyphenols and obesity
Shu Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury
Anne-Emilie Decleves et al.
KIDNEY INTERNATIONAL (2014)
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
Hiroki Fujita et al.
KIDNEY INTERNATIONAL (2014)
NAD+ and sirtuins in aging and disease
Shin-ichiro Imai et al.
TRENDS IN CELL BIOLOGY (2014)
Mitochondrial Plasticity in Obesity and Diabetes Mellitus
Tomas Jelenik et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection
Daisuke Katagiri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Obesity in CKD-What Should Nephrologists Know?
Peter Stenvinkel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
Kumar Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Effects of weight loss on renal function in obese CKD patients: a systematic review
Davide Bolignano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The role of taurine in renal disorders
Xiaobin Han et al.
AMINO ACIDS (2012)
The Link Between the Renin-Angiotensin-Aldosterone System and Renal Injury in Obesity and the Metabolic Syndrome
Tina Thethi et al.
CURRENT HYPERTENSION REPORTS (2012)
Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Akira Mima et al.
DIABETES (2012)
High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway
Hyun Wha Chung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation
C. Guillet et al.
OBESITY REVIEWS (2012)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes
R. Nosadini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice
Marisa J. S. Frederico et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Regulation of Inflammation by Short Chain Fatty Acids
Marco A. R. Vinolo et al.
NUTRIENTS (2011)
Obesity Related Kidney Disease
Anna V. Mathew et al.
CURRENT DIABETES REVIEWS (2011)
Renal lipid metabolism and lipotoxicity
Ion Alexandru Bobulescu
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
GLP-1 receptor signaling:: effects on pancreatic β-cell proliferation and survival
J. Buteau
DIABETES & METABOLISM (2008)
Association between obesity and kidney disease: A systematic review and meta-analysis
Y. Wang et al.
KIDNEY INTERNATIONAL (2008)
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not
Kirsten Raun et al.
DIABETES (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Body mass index and risk for end-stage renal disease
CY Hsu et al.
ANNALS OF INTERNAL MEDICINE (2006)
Association between body mass index and CKD in apparently healthy men
RP Gelber et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Predictors of new-onset kidney disease in a community-based population
CS Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Cardiovascular endocrinology 2 - Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents
MI Goran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
L-glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent
Z Zhong et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2003)
Blockade of the renin-angiotensin and endothelin systems on progressive renal injury
K Muenter et al.
HYPERTENSION (2001)
Share Paper
